Brugada syndrome: Controversies in Risk stratification and Management.

about

Brugada syndrome: Controversies in Risk stratification and Management.

Item

http://www.wikidata.org/entity/Q42431740

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Brugada syndrome: Controversies in Risk stratification and Management.

@en

Brugada syndrome: Controversies in Risk stratification and Management.

@nl

type

Item

label

Brugada syndrome: Controversies in Risk stratification and Management.

@en

Brugada syndrome: Controversies in Risk stratification and Management.

@nl

prefLabel

Brugada syndrome: Controversies in Risk stratification and Management.

@en

Brugada syndrome: Controversies in Risk stratification and Management.

@nl

P1476

Brugada syndrome: Controversies in Risk stratification and Management

@en

P2093

J Bhar-Amato

http://www.w3.org/2001/XMLSchema#string

Lm Nunn

http://www.w3.org/2001/XMLSchema#string

Pd Lambiase

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)

Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data.

Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification.

Brugada syndrome and supraventricular tachyarrhythmias: a novel association?

Natural history of Brugada syndrome: insights for risk stratification and management.

Role of signal-averaged electrocardiograms for predicting the inducibility of ventricular fibrillation in the syndrome consisting of right bundle branch block and ST segment elevation in leads V1-V3.

Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.

Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.

Hydroquinidine therapy in Brugada syndrome.

P304

400-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20930958

http://www.w3.org/2001/XMLSchema#string

P932

2933368

http://www.w3.org/2001/XMLSchema#string